|
| N-[3-(2-amino-1H-imidazol-5-yl)propyl]-4,5-dibromo-1-[(4-methoxyphenyl)methyl]pyrrole-2-carboxamide;hydrochloride |
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Richards JJ, et al. 2008. Bioorg Med Chem Lett |
|
| 1-(4-chlorophenoxy)-3-(2,6-dimethylpiperidin-1-yl)propan-2-ol |
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
| 1-[4-(2,3,5-trimethylphenoxy)butyl]piperidine |
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
| [2-hydroxy-3-(2,4,6-trimethylphenoxy)propyl]-(2,4,4-trimethylpentan-2-yl)azanium |
|
Bacillus |
Nutritional/Metabolic factor |
Preclinical (in vitro) |
Fernandes AS, et al. 2021. Front Microbiol |
|
| (3s)-3-Amino-1-[4-(Benzyloxy)phenyl]-4-(1h-Imidazol-4-Yl)butan-2-One |
|
Brucella |
Others |
Preclinical (in vitro) |
Abdo MR, et al. 2011. Org Biomol Chem |
|
PB-2.12
(internal name in literature) |
|
Clostridium
Streptococcus |
theta-toxin/PFO (Perfringolysin O)
Pneumolysin |
Preclinical (in vitro)
Preclinical (in vitro) |
Aziz UBA, et al. 2024. Nat Commun
|
|
| 4-(4-methoxyphenyl)-2-[4-(2-phenyl-1,3-thiazol-4-yl)phenyl]-1,3-thiazole |
|
Enterococcus
Staphylococcus |
Others; Adherence; Biofilm
Others; Adherence; Biofilm |
Preclinical (in vitro)
Preclinical (in vitro) |
Oniga SD, et al. 2017. Molecules
|
|
| ethyl 2-[(4Z)-4-[(3-bromo-4-methoxyphenyl)methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate |
|
Haemophilus |
LOS |
Preclinical (in vitro) |
Xu Y, et al. 2018. Bioorg Med Chem |
|
| 5beta,6alpha-Bis[4-(4-methoxyphenyl)-1H-1,2,3-triazole-1-ylmethyl]-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
| 4-Methoxy-beta-nitrostyrene |
|
Shigella |
VirF |
Preclinical (in vitro) |
Hurt JK, et al. 2010. J Biomol Screen |
|
| | | |
